Skip to main content
Meera Yogarajah, MD, Oncology, Bridgeton, MO

MeeraYogarajahMD

Oncology Bridgeton, MO

Hematologist & Oncologist

Dr. Yogarajah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yogarajah's full profile

Already have an account?

  • Office

    12277 De Paul Dr
    Ste 100
    Bridgeton, MO 63044
    Phone+1 314-209-5142

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2019
  • Vidant Medical Center/East Carolina University
    Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2015 - 2018
  • One Brooklyn Health System/Interfaith Medical Center
    One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 2012 - 2015

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2019 - 2025
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • MN State Medical License
    MN State Medical License 2018 - 2020
  • NC State Medical License
    NC State Medical License 2015 - 2019
  • NY State Medical License
    NY State Medical License 2015 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Discrepancy of blast percentage between the bone marrow aspirate and biopsy and its impact on survival outcomes in patients with myelodysplastic syndromes excess blast... 
    2019 ASCO Annual Meeting - 6/1/2019